breast cancer surgery modified mastectomy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - >18 years old - ASA I-III - Written informed consent
Exclusion criteria
Exclusion criteria: - Allergy or contra-indication for paracetamol, etoricoxib or oxycodone - Chronic opioid use - Known hypersensitivity or contraindication for local anesthetics - Bleeding or infection at the puncture site - Contraindications for regional anesthesia - Any other reason which in the opinion of the investigator makes the patient unsuitable for participation in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main study parameter is reduction in NRS pain score and/or opioid use compared with women undergoing standard care. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome measures are time to perform the procedure, patient discomfort during the procedure, extend of sensory block, patient satisfaction with post-operative analgesia, incidence of side-effects and complications. | — |
Countries
The Netherlands